Outcome of frozen-thawed blastocysts derived from gonadotropin releasing hormone agonist or antagonist cycles

Journal of Assisted Reproduction and Genetics

Volumn 23, Issue 6, 2006, Pages 275-279

  Medved, Robert ^a   Virant Klun, Irma ^a   Meden Vrtovec, Helena ^a   Tomaževič, Tomaž ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

ART; Frozen thawed blastocysts; GnRH agonists; GnRH antagonists

Indexed keywords

BUSERELIN ACETATE; CETRORELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BIRTH RATE; BLASTOCYST; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; INFERTILITY THERAPY; NIDATION; OUTCOME ASSESSMENT; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; BLASTOCYST; BUSERELIN; CRYOPRESERVATION; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; LIVE BIRTH; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; RETROSPECTIVE STUDIES;

EID: 33748805200     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-006-9051-3     Document Type: Article

References (22)

1. Felberbaum RE, Ludwig M, Lunenfeld B, Diedrich K: GnRH antagonists in assisted reproduction. In: Lunenfeld B, editor. GnRH analogues. The state of the Art 2001. London, The Parthenon Publishing Group; 2002. pp. 71-86
2. Tarlatzis BC: The use of GnRH antagonists in ovarian stimulation for assisted reproduction techniques. In: Meden-Vrtovec H, Pirc M, Trenkič M, editors. Proceedings of 2nd International Symposium on Assisted Reproduction of Slovenian Association of Reproductive Medicine. Ljubljana, Slovenian Association of Reproductive Medicine; 1999. p. 31
3. Daya S: GnRH agonists versus antagonists in assisted reproduction - A systematic review. In: Lunenfeld B, Emons G, editors. Proceedings of the 8th International Symposium on GnRH analogues in cancer and human reproduction. Final Program & Book of Abstracts. Salzburg, Kenes International; 2005. p. A100
4. Diedrich K, Felberbaum R, Schultze-Mosgau A, Griesinger G: GnRH agonist vs. GnRH antagonist: Is there a difference in the clinical results? Data from the German IVF registry (DIR). In: Lunenfeld B, Emons G, editors. Proceedings of the 8th International Symposium on GnRH analogues in cancer and human reproduction. Final Program & Book of Abstracts. Salzburg, Kenes International; 2005. p. A44
5. Medved R, Meden-Vrtovec H: Clinical experiences with GnRH antagonist administration in ART procedures. In: Meden-Vrtovec H, editor. Proceedings of the 3rd International Symposium on Assisted Reproduction of Slovenian Association of Reproductive Medicine. Ljubljana, Slovenian Association of Reproductive Medicine; 2003. pp. 43-5
6. Nikolettos N, Asimakopoulos B, Simopoulou M, Al-Hasani S, Diedrich K: Gonadotropin releasing hormone antagonists and cryopreservation outcome: A review. Arch Gynecol Obstet 2004;270:69-73
7. Meden-Vrtovec H, Virant-Klun I, Tomaževič T et al: Programme of in vitro fertilization at the department of obstetrics and gynaecology in Ljubljana. Zdrav Vestn 2001;70:89-95
8. Virant-Klun I, Tomazevic T, Bacer-Kermavner L, Mivsek J, Valentincic-Gruden B, Meden-Vrtovec H: Successful freezing and thawing of blastocysts cultured in sequential media using a modified method. Fertil Steril 2003;79:1428-33
9. Tomažzevič T, Geršak K, Meden-Vrtovec H et al: Clinical parameters to predict the success of in vitro fertilization-embryo transfer in the natural cycle. Assist Reprod 1999;9:149-56
10. Medved R: Gonadotropin-releasing hormone antagonists vs. agonists in in vitro fertilization. Master Thesis. Ljubljana, Medicinska fakulteta Univerze v Ljubljani; 2002
11. Albano C, Felberbaum RE, Smitz J et al: Ovarian stimulation with HMG: Results of a prospective randomised phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod 2000;15:526-31
12. The European Orgalutran® Study Group, Borm G, Mannaerts B: Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. Hum Reprod 2000;15:1490-8
13. Olivennes F, Belaisch-Allart J, Emperaire JC et al: Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril 2000;73:314-20
14. The European and Middle East Orgalutran® Study Group: Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 2001;16:644-51
15. The North American Ganirelix Study Group: Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 2001;75:38-45
16. Al-Inany H, Aboulghar M: GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 2002;17:874-85
17. Hernandez ER: Embryo implantation and GnRH antagonists. Embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod 2000;15:1211-6
18. Seelig AS, Al-Hasani S, Katalinic A et al: Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle. Fertil Steril 2002;77:472-5
19. Nikolettos N, Al-Hasani S, Felberbaum R et al: Comparison of cryopreservation outcome with human pronuclear stage oocytes obtained by the GnRH antagonist, Cetrorelix, and GnRH agonists. Eur J Obstet Gynecol Reprod Biol 2000;93:91-5
20. Asimakopoulos B, Nikolettos N, Al-Hasani S: Outcome of cryopreserved pronuclear oocytes obtained after ovarian stimulation with either HMG or recFSH and the GnRH-antagonist cetrorelix. Reprod Biomed Online 2002;5(Suppl 1,3):52-6
21. Kol S, Lightman A, Hillensjo T et al: High doses of gonadotrophin- releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Hum Reprod 1999;14:2242-4
22. Zikopoulos K, Kolibianakis EM, Camus M et al: Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cycles. Fertil Steril 2004;81:473-5